Hilltop Holdings’s Pfizer PFE Stock Holding History

Hilltop Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.54M	Sell	126,065 -47,883	-28%	-$1.27M	0.32%	72
2025 Q4	$4.33M	Buy	173,948 +13,321	+8%	+$336K	0.26%	91
2025 Q3	$4.09M	Buy	160,627 +38,758	+32%	+$957K	0.22%	108
2025 Q2	$2.95M	Buy	121,869 +10,013	+9%	+$234K	0.19%	129
2025 Q1	$2.83M	Buy	111,856 +12,922	+13%	+$338K	0.18%	136
2024 Q4	$2.62M	Sell	98,934 -3,419	-3%	-$92.7K	0.17%	146
2024 Q3	$2.96M	Buy	102,353 +24,736	+32%	+$722K	0.19%	127
2024 Q2	$2.17M	Buy	77,617 +51	+0.1%	+$1.4K	0.25%	97
2024 Q1	$2.15M	Buy	77,566 +254	+0.3%	+$7.05K	0.22%	113
2023 Q4	$2.23M	Sell	77,312 -2,097	-3%	-$63.4K	0.25%	114
2023 Q3	$2.63M	Buy	79,409 +11,225	+16%	+$397K	0.31%	88
2023 Q2	$2.5M	Sell	68,184 -7,743	-10%	-$301K	0.3%	82
2023 Q1	$3.1M	Buy	75,927 +5,658	+8%	+$244K	0.41%	57
2022 Q4	$3.6M	Sell	70,269 -1,071	-2%	-$51.3K	0.46%	55
2022 Q3	$3.12M	Sell	71,340 -7,501	-10%	-$364K	0.42%	53
2022 Q2	$4.13M	Buy	78,841 +5,290	+7%	+$270K	0.55%	42
2022 Q1	$3.81M	Sell	73,551 -594	-0.8%	-$30.8K	0.43%	49
2021 Q4	$4.38M	Sell	74,145 -2,412	-3%	-$120K	0.45%	51
2021 Q3	$3.29M	Buy	76,557 +7,342	+11%	+$325K	0.36%	61
2021 Q2	$2.71M	Buy	69,215 +10,315	+18%	+$401K	0.31%	74
2021 Q1	$2.13M	Sell	58,900 -26,488	-31%	-$940K	0.28%	80
2020 Q4	$3.14M	Sell	85,388 -16,587	-16%	-$608K	0.44%	47
2020 Q3	$3.55M	Sell	101,975 -1,075	-1%	-$37.7K	0.6%	34
2020 Q2	$3.2M	Buy	103,050 +11,529	+13%	+$392K	0.59%	33
2020 Q1	$2.83M	Sell	91,521 -11,693	-11%	-$398K	0.68%	28
2019 Q4	$3.84M	Buy	103,214 +8,402	+9%	+$299K	0.72%	28
2019 Q3	$3.23M	Buy	94,812 +12,725	+16%	+$463K	0.61%	35
2019 Q2	$3.37M	Buy	82,087 +5,323	+7%	+$211K	0.72%	32
2019 Q1	$3.09M	Buy	76,764 +41,657	+119%	+$1.67M	0.66%	37
2018 Q4	$1.45M	Sell	35,107 -5,369	-13%	-$223K	0.36%	70
2018 Q3	$1.69M	Buy	40,476 +5,900	+17%	+$227K	0.35%	75
2018 Q2	$1.19M	Sell	34,576 -1,074	-3%	-$36.7K	0.25%	102
2018 Q1	$1.2M	Sell	35,650 -41,001	-53%	-$1.41M	0.21%	120
2017 Q4	$2.63M	Buy	76,651 +8,920	+13%	+$304K	0.59%	35
2017 Q3	$2.29M	Sell	67,731 -4,954	-7%	-$159K	0.69%	37
2017 Q2	$2.32M	Buy	72,685 +1,396	+2%	+$44K	0.68%	36
2017 Q1	$2.31M	Sell	71,289 -4,288	-6%	-$135K	0.7%	35
2016 Q4	$2.33M	Buy	75,577 +19,854	+36%	+$606K	0.73%	33
2016 Q3	$1.79M	Buy	55,723 +1,202	+2%	+$40.2K	0.56%	51
2016 Q2	$1.82M	Sell	54,521 -711	-1%	-$22.7K	0.58%	46
2016 Q1	$1.55M	Sell	55,232 -5,294	-9%	-$151K	0.49%	60
2015 Q4	$1.85M	Buy	60,526 +1,134	+2%	+$35.7K	0.54%	53
2015 Q3	$1.77M	Buy	59,392 +459	+0.8%	+$14.7K	0.52%	56
2015 Q2	$1.88M	Buy	58,933 +247	+0.4%	+$8.05K	0.51%	64
2015 Q1	$1.94M	Buy	58,686 +45,953	+361%	+$1.46M	0.49%	62
2014 Q4	$377K	Buy	12,733 +948	+8%	+$27.2K	0.13%	138
2014 Q3	$331K	Buy	11,785 +179	+2%	+$5.02K	0.15%	146
2014 Q2	$327K	Sell	11,606 -12,483	-52%	-$356K	0.15%	156
2014 Q1	$734K	Buy	24,089 +2,519	+12%	+$75.1K	0.37%	80
2013 Q4	$626K	Buy	+21,570	New	+$628K	0.32%	87

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hilltop Holdings's PFE Position: Q1 2026 in Review

Hilltop Holdings reduced its Pfizer (PFE) stake by 28% in Q1 2026, selling an estimated $1.27M and leaving 126,065 shares worth $3.54M. The position accounts for 0.32% of the portfolio, ranked #72.

Hilltop Holdings first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.38M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Hilltop Holdings held 126,065 shares of Pfizer worth $3.54M as of Q1 2026.
Hilltop Holdings sold 47,883 Pfizer shares in Q1 2026, an estimated $1.27M.
Pfizer made up 0.32% of Hilltop Holdings's portfolio in Q1 2026, its #72 holding.
Hilltop Holdings first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
Hilltop Holdings's Pfizer position peaked at $4.38M in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.